Chk1/2蛋白在胶质瘤和正常脑组织中的分布及意义(3)
[2] Constantine A, Monteagado O, Merino HJ, et al.Immunohistochemical detection of Pglycoprotein in endometrial adenocarcinoma.Am J Pathol, 1991, 138: 799806.
[3] Sanchez Y, Wong C, Thoma RS, et al.Conservation of the CHK1 checkpoint pathway in mammals: linkage of DNA damage to CDK regulation through Cdc25Science, 1997, 277(5331):14971501.
[4] Matsuoka S, Huang M, Elledge SJ.Linkage of ATM to cell cycle 39 regulation by the CHK2 protein kinase.Science, 1998, 282(5395):18931897.
[5] Hirose Y, Berger MS, Pieper RO.Abrogation of the CHK1mediated G(2) checkpoint pathway potentiates temozolomideinduced toxicity in ap53independent manner in human glioblastoma cells.Cancer Res, 2001, 61(15):58435849.
[6] 吴承远,刘玉光.临床神经外科学.北京：人民卫生出版社，2001:233248.
[7] Shigeishi H, Yokozaki H, Oue N,et al.Increased expression of CHK2 in human gastriccarcinomas harboring p53 mutations.Int J Cancer, 2002, 99:58.
[8] Zenvirt S, KravchenkoBalasha N, Levitzki A.Status of p53 in human cancer cells does not predict efficacy of CHK1 kinaseinhibitors combined with chemotherapeutic agents.Oncogene, 2010,29:61496159.
[9] Yeh Y, Huang Y, Lin TY, et al.The cell cycle checkpoint kinase CHK2 mediates DNA damageinduced stabilization of TTK/hMps1Oncogene, 2009, 28(10):13661378.脑梗死合并代谢综合征126例临床分析, 百拇医药(李勇 赖润龙 谭殿辉 陈煜 雷霆)
[3] Sanchez Y, Wong C, Thoma RS, et al.Conservation of the CHK1 checkpoint pathway in mammals: linkage of DNA damage to CDK regulation through Cdc25Science, 1997, 277(5331):14971501.
[4] Matsuoka S, Huang M, Elledge SJ.Linkage of ATM to cell cycle 39 regulation by the CHK2 protein kinase.Science, 1998, 282(5395):18931897.
[5] Hirose Y, Berger MS, Pieper RO.Abrogation of the CHK1mediated G(2) checkpoint pathway potentiates temozolomideinduced toxicity in ap53independent manner in human glioblastoma cells.Cancer Res, 2001, 61(15):58435849.
[6] 吴承远,刘玉光.临床神经外科学.北京：人民卫生出版社，2001:233248.
[7] Shigeishi H, Yokozaki H, Oue N,et al.Increased expression of CHK2 in human gastriccarcinomas harboring p53 mutations.Int J Cancer, 2002, 99:58.
[8] Zenvirt S, KravchenkoBalasha N, Levitzki A.Status of p53 in human cancer cells does not predict efficacy of CHK1 kinaseinhibitors combined with chemotherapeutic agents.Oncogene, 2010,29:61496159.
[9] Yeh Y, Huang Y, Lin TY, et al.The cell cycle checkpoint kinase CHK2 mediates DNA damageinduced stabilization of TTK/hMps1Oncogene, 2009, 28(10):13661378.脑梗死合并代谢综合征126例临床分析, 百拇医药(李勇 赖润龙 谭殿辉 陈煜 雷霆)